双特异性抗体的免疫治疗潜力。 - Suppr

Suppr

超能文献

Immunotherapeutic potential of bispecific antibodies.

作者信息

van de Winkel J G, Bast B, de Gast G C

机构信息

Dept of Immunology, University Hospital Utrecht, The Netherlands.

出版信息

Immunol Today. 1997 Dec;18(12):562-4. doi: 10.1016/s0167-5699(97)01167-5.

DOI:10.1016/s0167-5699(97)01167-5

PMID:9425731

Abstract

摘要

相似文献

Immunotherapeutic potential of bispecific antibodies.

Immunol Today. 1997 Dec;18(12):562-4. doi: 10.1016/s0167-5699(97)01167-5.

Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies.

Immunol Today. 1997 Mar;18(3):127-35. doi: 10.1016/s0167-5699(97)01007-4.

Selective silencing of autoreactive B lymphocytes-Following the Nature's way.

Autoimmun Rev. 2010 Sep;9(11):775-9. doi: 10.1016/j.autrev.2010.06.010. Epub 2010 Jul 1.

The therapeutic potential of the targeted autoreactive B lymphocytes by rituximab in SLE.

Autoimmun Rev. 2012 Mar;11(5):373. doi: 10.1016/j.autrev.2011.01.002. Epub 2011 Jan 9.

Bispecific antibodies and diabodies for cancer immunotherapy.

Immunotherapy. 2012 May;4(5):459-60. doi: 10.2217/imt.12.18.

Immunotherapeutic perspective for bispecific antibodies.

Immunol Today. 2000 Aug;21(8):391-7. doi: 10.1016/s0167-5699(00)01659-5.

The emerging therapeutic role of antibody mixtures.

Expert Opin Biol Ther. 2013 Jul;13(7):953-8. doi: 10.1517/14712598.2013.799133. Epub 2013 May 7.

Advances in bispecific biotherapeutics for the treatment of cancer.

Biochem Pharmacol. 2012 Nov 1;84(9):1105-12. doi: 10.1016/j.bcp.2012.07.011. Epub 2012 Jul 25.

Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.

Mol Immunol. 2009 Nov;47(1):123-30. doi: 10.1016/j.molimm.2009.01.013. Epub 2009 Feb 24.

Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancer.

Expert Opin Biol Ther. 2015;15(8):1093-9. doi: 10.1517/14712598.2015.1041373. Epub 2015 May 13.

引用本文的文献

Modulation of tumor growth by inhibitory Fc(gamma) receptor expressed by human melanoma cells.

J Clin Invest. 2002 Nov;110(10):1549-57. doi: 10.1172/JCI15454.

Selection of single chain variable fragments (scFv) against the glycoprotein antigen of the rabies virus from a human synthetic scFv phage display library and their fusion with the Fc region of human IgG1.

Clin Exp Immunol. 2001 Jul;125(1):94-101. doi: 10.1046/j.1365-2249.2001.01515.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Immunotherapeutic potential of bispecific antibodies.

作者信息

van de Winkel J G, Bast B, de Gast G C

机构信息

Dept of Immunology, University Hospital Utrecht, The Netherlands.

出版信息

Immunol Today. 1997 Dec;18(12):562-4. doi: 10.1016/s0167-5699(97)01167-5.

DOI:10.1016/s0167-5699(97)01167-5

PMID:9425731

Abstract

摘要

相似文献

Immunotherapeutic potential of bispecific antibodies.

Immunol Today. 1997 Dec;18(12):562-4. doi: 10.1016/s0167-5699(97)01167-5.

Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies.

Immunol Today. 1997 Mar;18(3):127-35. doi: 10.1016/s0167-5699(97)01007-4.

Selective silencing of autoreactive B lymphocytes-Following the Nature's way.

Autoimmun Rev. 2010 Sep;9(11):775-9. doi: 10.1016/j.autrev.2010.06.010. Epub 2010 Jul 1.

The therapeutic potential of the targeted autoreactive B lymphocytes by rituximab in SLE.

Autoimmun Rev. 2012 Mar;11(5):373. doi: 10.1016/j.autrev.2011.01.002. Epub 2011 Jan 9.

Bispecific antibodies and diabodies for cancer immunotherapy.

Immunotherapy. 2012 May;4(5):459-60. doi: 10.2217/imt.12.18.

Immunotherapeutic perspective for bispecific antibodies.

Immunol Today. 2000 Aug;21(8):391-7. doi: 10.1016/s0167-5699(00)01659-5.

The emerging therapeutic role of antibody mixtures.

Expert Opin Biol Ther. 2013 Jul;13(7):953-8. doi: 10.1517/14712598.2013.799133. Epub 2013 May 7.

Advances in bispecific biotherapeutics for the treatment of cancer.

Biochem Pharmacol. 2012 Nov 1;84(9):1105-12. doi: 10.1016/j.bcp.2012.07.011. Epub 2012 Jul 25.

Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.

Mol Immunol. 2009 Nov;47(1):123-30. doi: 10.1016/j.molimm.2009.01.013. Epub 2009 Feb 24.

Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancer.

Expert Opin Biol Ther. 2015;15(8):1093-9. doi: 10.1517/14712598.2015.1041373. Epub 2015 May 13.

引用本文的文献

Modulation of tumor growth by inhibitory Fc(gamma) receptor expressed by human melanoma cells.

J Clin Invest. 2002 Nov;110(10):1549-57. doi: 10.1172/JCI15454.

Clin Exp Immunol. 2001 Jul;125(1):94-101. doi: 10.1046/j.1365-2249.2001.01515.x.